Age‐related macular degeneration and myeloproliferative neoplasms – A common pathway

por Liisborg, Charlotte
Publicado 2022

Ocular Manifestations in Patients with Philadelphia-Negative Myeloproliferative Neoplasms

por Liisborg, Charlotte, Hasselbalch, Hans Carl, Sørensen, Torben Lykke
Publicado 2020

Patients with myeloproliferative neoplasms and high levels of systemic inflammation develop age-related macular degeneration

por Liisborg, Charlotte, Nielsen, Marie Krogh, Hasselbalch, Hans Carl, Sørensen, Torben Lykke
Publicado 2020

Retinal drusen in patients with chronic myeloproliferative blood cancers are associated with an increased proportion of senescent T cells and signs of an aging immune system

por Liisborg, Charlotte, Skov, Vibe, Kjær, Lasse, Hasselbalch, Hans Carl, Sørensen, Torben Lykke
Publicado 2021

Patients with MPNs and retinal drusen show signs of complement system dysregulation and a high degree of chronic low-grade inflammation

por Liisborg, Charlotte, Skov, Vibe, Kjær, Lasse, Hasselbalch, Hans Carl, Sørensen, Torben Lykke
Publicado 2021

Lower CXCR3 expression in both patients with neovascular AMD and advanced stages of chronic myeloproliferative blood cancers

por Liisborg, Charlotte, Skov, Vibe, Kjær, Lasse, Hasselbalch, Hans Carl, Lykke Sørensen, Torben
Publicado 2022

Serum levels of IL-4, IL-13 and IL-33 in patients with age-related macular degeneration and myeloproliferative neoplasms

por Gotfredsen, Kathrine, Liisborg, Charlotte, Skov, Vibe, Kjær, Lasse, Hasselbalch, Hans Carl, Sørensen, Torben Lykke
Publicado 2023

The transcriptome of peripheral blood mononuclear cells in patients with clinical subtypes of late age-related macular degeneration

por Subhi, Yousif, Nielsen, Marie Krogh, Molbech, Christopher Rue, Liisborg, Charlotte, Søndergaard, Helle Bach, Sellebjerg, Finn, Sørensen, Torben Lykke
Publicado 2019